Gene–environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington’s disease transgenic mice

Huntington's disease (HD) is a fatal neurodegenerative disorder characterized by motor, cognitive and psychiatric symptoms. Here, we show that R6/1 (HD) mice have deficits in short-term hippocampal-dependent memory prior to onset of motor symptoms. HD mice also exhibit impaired performance on a test of long-term spatial memory, however, environmental enrichment enhanced spatial learning and significantly ameliorated this memory deficit in HD mice. Analysis of the presynaptic vesicle protein synaptophysin showed no differences between standard-housed wild-type and HD littermates, however, enrichment increased synaptophysin levels in the frontal cortex and hippocampus in both groups. In comparison, analysis of postsynaptic proteins revealed that HD animals show decreased levels of PSD-95 and GluR1, but no change in levels of gephyrin. Furthermore, at 12 weeks of age when we observe a beneficial effect of enrichment on spatial learning in HD mice, enrichment also delays the onset of a deficit in hippocampal PSD-95 levels. Our results show that cognitive deficits in HD mice can be ameliorated by environmental enrichment and suggest that changes in synaptic composition may contribute to the cognitive alterations observed.

[1]  Jacki Y. Brown,et al.  Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. , 2006, Human molecular genetics.

[2]  A. Morton,et al.  Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease , 2001, Journal of neurochemistry.

[3]  J. Nithianantharajah,et al.  Environmental enrichment results in cortical and subcortical changes in levels of synaptophysin and PSD-95 proteins , 2004, Neurobiology of Learning and Memory.

[4]  M. Hayden,et al.  Cognitive Dysfunction Precedes Neuropathology and Motor Abnormalities in the YAC128 Mouse Model of Huntington's Disease , 2005, The Journal of Neuroscience.

[5]  J. Brandt,et al.  Differential impairment of spatial location memory in Huntington’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  A. Morton,et al.  Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease Mutation , 1999, The Journal of Neuroscience.

[7]  S B Dunnett,et al.  Abnormal Synaptic Plasticity and Impaired Spatial Cognition in Mice Transgenic for Exon 1 of the Human Huntington's Disease Mutation , 2000, The Journal of Neuroscience.

[8]  J. Lübke,et al.  Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. , 1999, Science.

[9]  T. Robbins,et al.  Executive and mnemonic functions in early Huntington's disease. , 1996, Brain : a journal of neurology.

[10]  Carlos Cepeda,et al.  Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease , 2003, The Journal of Neuroscience.

[11]  M. Chesselet,et al.  Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. , 2001, Journal of neurophysiology.

[12]  Wilhelm Gaus,et al.  Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis , 2004, Neurology.

[13]  Dane M. Chetkovich,et al.  Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms , 2000, Nature.

[14]  T. Südhof,et al.  Neuroligin 1: A splice site-specific ligand for β-neurexins , 1995, Cell.

[15]  M. W. Brown,et al.  Episodic memory, amnesia, and the hippocampal–anterior thalamic axis , 1999, Behavioral and Brain Sciences.

[16]  C. Garner,et al.  SAP90 Binds and Clusters Kainate Receptors Causing Incomplete Desensitization , 1998, Neuron.

[17]  Suzanne Imbriglio Environmental Enrichment Slows Disease Progression in R6/2 Huntingtonʼs Disease Mice. , 2002 .

[18]  S. Dunnett,et al.  Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease , 2006, Brain Research Bulletin.

[19]  D. Lockhart,et al.  Effects of environmental enrichment on gene expression in the brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Karen Marder,et al.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Rubinsztein,et al.  Transcriptional abnormalities in Huntington disease. , 2003, Trends in genetics : TIG.

[22]  K. Fujisawa,et al.  Citron, a Rho-Target, Interacts with PSD-95/SAP-90 at Glutamatergic Synapses in the Thalamus , 1999, The Journal of Neuroscience.

[23]  J Palo,et al.  [Huntington's disease]. , 1986, Duodecim; laaketieteellinen aikakauskirja.

[24]  C. Blakemore,et al.  Deficits in Experience-Dependent Cortical Plasticity and Sensory-Discrimination Learning in Presymptomatic Huntington's Disease Mice , 2005, The Journal of Neuroscience.

[25]  C. Belzung,et al.  Environmental enrichment in BALB/c mice Effects in classical tests of anxiety and exposure to a predatory odor , 2001, Physiology & Behavior.

[26]  T. Robbins,et al.  Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. , 2000, Brain : a journal of neurology.

[27]  Peter S. Harper,et al.  Huntington's disease , 1991 .

[28]  P. Seeburg,et al.  Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. , 1995, Science.

[29]  Jacki Y. Brown,et al.  Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. , 2006, Human molecular genetics.

[30]  Nathan C. Stam,et al.  Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in huntington’s disease transgenic mice , 2006, Neuroscience.

[31]  T. Südhof,et al.  Binding of neuroligins to PSD-95. , 1997, Science.

[32]  E. Vandenbussche,et al.  Cognitive changes in patients with Huntington’s disease (HD) and asymptomatic carriers of the HD mutation , 2004, Journal of Neurology.

[33]  Ruth Luthi-Carter,et al.  Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation , 2003, Neurobiology of Disease.

[34]  Malcolm W. Brown,et al.  Recognition memory: What are the roles of the perirhinal cortex and hippocampus? , 2001, Nature Reviews Neuroscience.

[35]  Helen E. Gibson,et al.  A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse , 2005, The European journal of neuroscience.

[36]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[37]  R. Myers,et al.  Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. , 1999, Human molecular genetics.

[38]  P. Reddy,et al.  Polyglutamine-expanded Huntingtin Promotes Sensitization of N-Methyl-d-aspartate Receptors via Post-synaptic Density 95* , 2001, The Journal of Biological Chemistry.

[39]  S. Gammie,et al.  Environmental enrichment alters plus maze, but not maternal defense performance in mice , 2005, Physiology & Behavior.

[40]  S. W. Davies,et al.  Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Robbins,et al.  The effects of intradimensional and extradimensional shifts on visual discrimination learning in humans and non-human primates , 1988, The Quarterly journal of experimental psychology. B, Comparative and physiological psychology.

[42]  N. Butters,et al.  Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. , 1978, Archives of neurology.

[43]  C A Ross,et al.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. , 2000, Human molecular genetics.

[44]  T. Südhof,et al.  Neuroligin 1: a splice site-specific ligand for beta-neurexins. , 1995, Cell.

[45]  C. Blakemore,et al.  Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine , 2005, The European journal of neuroscience.

[46]  Thomas Walther,et al.  Transgenic rat model of Huntington's disease. , 2003, Human molecular genetics.

[47]  E. Vandenbussche,et al.  Longitudinal study evaluating neuropsychological changes in so‐called asymptomatic carriers of the Huntington's disease mutation after 1 year , 2002, Acta neurologica Scandinavica.

[48]  J. Caston,et al.  Rearing Environmental Enrichment in Two Inbred Strains of Mice: 1. Effects on Emotional Reactivity , 1999, Behavior genetics.

[49]  J. Rawlins,et al.  Spatial reference memory in GluR‐A‐deficient mice using a novel hippocampal‐dependent paddling pool escape task , 2004, Hippocampus.

[50]  H. Ralston,et al.  Localization of Postsynaptic Density-93 to Dendritic Microtubules and Interaction with Microtubule-Associated Protein 1A , 1998, The Journal of Neuroscience.

[51]  Ann Marie Craig,et al.  CRIPT, a Novel Postsynaptic Protein that Binds to the Third PDZ Domain of PSD-95/SAP90 , 1998, Neuron.

[52]  R. Nicoll,et al.  Postsynaptic Density-95 Mimics and Occludes Hippocampal Long-Term Potentiation and Enhances Long-Term Depression , 2003, The Journal of Neuroscience.

[53]  R. D. Hunt,et al.  Huntington's dementia. Clinical and neuropsychological features. , 1978, Archives of general psychiatry.

[54]  R. Morris,et al.  Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein , 1998, Nature.

[55]  Colin Blakemore,et al.  Delaying the onset of Huntington's in mice , 2000, Nature.

[56]  J. Zarranz,et al.  Monozygotic Twins Suffering from Huntington’s Disease Show Different Cognitive and Behavioural Symptoms , 2006, European Neurology.

[57]  T. Südhof,et al.  Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Kennedy,et al.  Citron Binds to PSD-95 at Glutamatergic Synapses on Inhibitory Neurons in the Hippocampus , 1999, The Journal of Neuroscience.

[59]  E. Kandel,et al.  Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal ltp in the range of the θ frequency , 1995, Cell.

[60]  E. Mancall,et al.  Development of neuropsychological deficits in Huntington's disease. , 1983, Archives of neurology.

[61]  Sebastian Pascarelle,et al.  Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68 , 2000, Nature.

[62]  V. Bolivar,et al.  Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice , 2004, Brain Research.

[63]  I. Yaniv,et al.  Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity , 2004, The European journal of neuroscience.

[64]  C. Blakemore,et al.  Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism , 2004, The Journal of Neuroscience.

[65]  Claire-Anne Gutekunst,et al.  A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.

[66]  A E Rosser,et al.  Evidence for specific cognitive deficits in preclinical Huntington's disease. , 1998, Brain : a journal of neurology.

[67]  Mauro Delorenzi,et al.  Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. , 2007, Human molecular genetics.